Evaluation of 14 commercial HIV-1/HIV-2 antibody assays using serum panels of different geographical origin and clinical stage including a unique seroconversion panel
Authors:
- Rigmor ThorstenssonRTRigmor Thorstensson
- Sören AnderssonSASören Andersson
- Stefan LindbäckSLStefan Lindbäck
- Francisco DiasFDFrancisco Dias
- Fred MhaluFMFred Mhalu
- Hans GainesHGHans Gaines
- Gunnel BiberfeldGBGunnel Biberfeld
- 1 February 1998
- journal article
- Published by Elsevier in Journal of Virological Methods
- Vol. 70 (2) , 139-151
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Most HIV-1 genetic subtypes have entered SwedenAIDS, 1997
- Optimisation of a peptide-based indirect ELISA for the detection of antibody in the serum of HIV-1 seropositive patientsJournal of Immunological Methods, 1997
- Lack of screening test sensitivity during HIV-1 non-subtype B seroconversionsAIDS, 1996
- Difficulties and strategies of HIV diagnosisThe Lancet, 1996
- False Negative Anti‐HIV‐1/HlV‐2 ELlSAs in Acute HIV‐2 InfectionVox Sanguinis, 1996
- Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donorsTransfusion, 1995
- Sensitivity of HIV-antibody assays determined by seroconversion panelsAIDS, 1994
- Comparative performance of peptide-, recombinant protein-, and viral lysate-based enzyme immunosorbent assays for the detection of HIV-1 antibodiesDiagnostic Microbiology and Infectious Disease, 1993
- A comparison of four enzyme immunoassays for the simultaneous detection of HIV-1- and HIV-2-specific antibodyJournal of Virological Methods, 1991
- Evaluation of commercial enzyme immunoassays for anti-HIV-1 using East African seraAIDS, 1988